CD8A and COVID-19: In addition, testing for delayed-type hypersensitivity responses, as shown recently by Barrios et al. [38] for recovering COVID-19 patients, may also provide valuable insights on the importance of cellular immune responses mediated by CD8+ T cells that directly kill virally infected cells as an additional defense mechanism for prospective vaccinees.